nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2B6—Methimazole—Graves' disease	0.403	0.412	CbGbCtD
Pethidine—CYP2C19—Methimazole—Graves' disease	0.256	0.262	CbGbCtD
Pethidine—CYP2D6—Methimazole—Graves' disease	0.195	0.199	CbGbCtD
Pethidine—CYP3A4—Methimazole—Graves' disease	0.124	0.127	CbGbCtD
Pethidine—Methylphenobarbital—GABRA3—Graves' disease	0.00461	1	CrCbGaD
Pethidine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.000652	0.0401	CbGpPWpGaD
Pethidine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000619	0.0382	CbGpPWpGaD
Pethidine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000576	0.0355	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.000576	0.0355	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.000487	0.03	CbGpPWpGaD
Pethidine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000473	0.0291	CbGpPWpGaD
Pethidine—GRIN2C—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000466	0.0287	CbGpPWpGaD
Pethidine—SLC6A4—Serotonin Transporter Activity—IL1B—Graves' disease	0.000465	0.0286	CbGpPWpGaD
Pethidine—GRIN2D—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000433	0.0267	CbGpPWpGaD
Pethidine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000412	0.0254	CbGpPWpGaD
Pethidine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000402	0.0248	CbGpPWpGaD
Pethidine—GRIN2C—Neuronal System—GABRA3—Graves' disease	0.000357	0.022	CbGpPWpGaD
Pethidine—GRIN2A—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000356	0.0219	CbGpPWpGaD
Pethidine—OPRK1—Peptide GPCRs—TSHR—Graves' disease	0.000332	0.0205	CbGpPWpGaD
Pethidine—GRIN2D—Neuronal System—GABRA3—Graves' disease	0.000332	0.0204	CbGpPWpGaD
Pethidine—GRIN2C—Alzheimers Disease—FAS—Graves' disease	0.000329	0.0202	CbGpPWpGaD
Pethidine—GRIN1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00031	0.0191	CbGpPWpGaD
Pethidine—GRIN2D—Alzheimers Disease—FAS—Graves' disease	0.000305	0.0188	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000302	0.0186	CbGpPWpGaD
Pethidine—OPRM1—Peptide GPCRs—TSHR—Graves' disease	0.000281	0.0173	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—GABRA3—Graves' disease	0.000272	0.0168	CbGpPWpGaD
Pethidine—GRIN2A—Alzheimers Disease—FAS—Graves' disease	0.000251	0.0154	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—GABRA3—Graves' disease	0.000238	0.0146	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—GABRA3—Graves' disease	0.000232	0.0143	CbGpPWpGaD
Pethidine—GRIN1—Alzheimers Disease—FAS—Graves' disease	0.000219	0.0135	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—FAS—Graves' disease	0.000213	0.0131	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—CXCL10—Graves' disease	0.000206	0.0127	CbGpPWpGaD
Pethidine—SLC6A4—Monoamine Transport—IL1B—Graves' disease	0.000198	0.0122	CbGpPWpGaD
Pethidine—GRIN2C—Alzheimers Disease—IL1B—Graves' disease	0.000192	0.0118	CbGpPWpGaD
Pethidine—GRIN2D—Alzheimers Disease—IL1B—Graves' disease	0.000179	0.011	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000177	0.0109	CbGpPWpGaD
Pethidine—SLC6A2—Monoamine Transport—IL1B—Graves' disease	0.00017	0.0105	CbGpPWpGaD
Pethidine—SLC6A3—Monoamine Transport—IL1B—Graves' disease	0.000151	0.00928	CbGpPWpGaD
Pethidine—GRIN2A—Alzheimers Disease—IL1B—Graves' disease	0.000147	0.00904	CbGpPWpGaD
Pethidine—SLC6A4—Monoamine Transport—TNF—Graves' disease	0.000144	0.00884	CbGpPWpGaD
Pethidine—GRIN2C—Alzheimers Disease—TNF—Graves' disease	0.000139	0.00859	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—ICAM1—Graves' disease	0.000137	0.00843	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—GABRA3—Graves' disease	0.000136	0.00836	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—CD8A—Graves' disease	0.000132	0.00811	CbGpPWpGaD
Pethidine—GRIN2D—Alzheimers Disease—TNF—Graves' disease	0.00013	0.00799	CbGpPWpGaD
Pethidine—GRIN1—Alzheimers Disease—IL1B—Graves' disease	0.000128	0.00788	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—IL1B—Graves' disease	0.000125	0.00768	CbGpPWpGaD
Pethidine—SLC6A2—Monoamine Transport—TNF—Graves' disease	0.000123	0.0076	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—FAS—Graves' disease	0.000119	0.00735	CbGpPWpGaD
Pethidine—SLC6A3—Monoamine Transport—TNF—Graves' disease	0.000109	0.00673	CbGpPWpGaD
Pethidine—GRIN2A—Alzheimers Disease—TNF—Graves' disease	0.000106	0.00656	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000105	0.00646	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IFNG—Graves' disease	0.000104	0.00641	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.000101	0.00622	CbGpPWpGaD
Pethidine—GRIN1—Alzheimers Disease—TNF—Graves' disease	9.29e-05	0.00572	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IL1B—Graves' disease	9.29e-05	0.00572	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—TNF—Graves' disease	9.05e-05	0.00558	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	8.86e-05	0.00546	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	8.68e-05	0.00534	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CXCL10—Graves' disease	8.54e-05	0.00526	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CXCL10—Graves' disease	8.52e-05	0.00525	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.24e-05	0.00507	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—TSHR—Graves' disease	7.99e-05	0.00492	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—FAS—Graves' disease	7.77e-05	0.00479	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—CD4—Graves' disease	7.56e-05	0.00466	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—IL1B—Graves' disease	7.43e-05	0.00457	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.3e-05	0.0045	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CXCL10—Graves' disease	7.2e-05	0.00444	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—ICAM1—Graves' disease	7.06e-05	0.00435	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—IL1B—Graves' disease	6.98e-05	0.0043	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	6.78e-05	0.00417	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—TSHR—Graves' disease	6.75e-05	0.00416	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—TNF—Graves' disease	6.74e-05	0.00415	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	6.6e-05	0.00407	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	5.89e-05	0.00363	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	5.73e-05	0.00353	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	5.61e-05	0.00345	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.57e-05	0.00343	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—TNF—Graves' disease	5.39e-05	0.00332	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IFNG—Graves' disease	5.37e-05	0.00331	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCL10—Graves' disease	5.16e-05	0.00318	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL1B—Graves' disease	4.79e-05	0.00295	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.68e-05	0.00288	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—TSHR—Graves' disease	4.51e-05	0.00278	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCL10—Graves' disease	4.36e-05	0.00269	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	4.27e-05	0.00263	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	4.27e-05	0.00263	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.2e-05	0.00259	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	4.14e-05	0.00255	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—TSHR—Graves' disease	4.1e-05	0.00252	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—TNF—Graves' disease	4.04e-05	0.00249	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—TSHR—Graves' disease	3.81e-05	0.00235	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	3.81e-05	0.00234	CbGpPWpGaD
Pethidine—Drowsiness—Methimazole—Graves' disease	3.61e-05	0.0923	CcSEcCtD
Pethidine—ALB—Folate Metabolism—TNF—Graves' disease	3.48e-05	0.00214	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—TSHR—Graves' disease	3.46e-05	0.00213	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	3.1e-05	0.00191	CbGpPWpGaD
Pethidine—Drowsiness—Propylthiouracil—Graves' disease	3.07e-05	0.0785	CcSEcCtD
Pethidine—OPRK1—GPCR downstream signaling—CXCL10—Graves' disease	2.92e-05	0.0018	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—TNF—Graves' disease	2.76e-05	0.0017	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL10—Graves' disease	2.65e-05	0.00163	CbGpPWpGaD
Pethidine—Vertigo—Methimazole—Graves' disease	2.53e-05	0.0648	CcSEcCtD
Pethidine—CYP2B6—Metabolism—GC—Graves' disease	2.48e-05	0.00153	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL10—Graves' disease	2.46e-05	0.00152	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSHR—Graves' disease	2.42e-05	0.00149	CbGpPWpGaD
Pethidine—Oedema—Methimazole—Graves' disease	2.3e-05	0.0589	CcSEcCtD
Pethidine—OPRM1—Signaling by GPCR—CXCL10—Graves' disease	2.24e-05	0.00138	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2RA—Graves' disease	2.23e-05	0.00137	CbGpPWpGaD
Pethidine—Vertigo—Propylthiouracil—Graves' disease	2.15e-05	0.0551	CcSEcCtD
Pethidine—GRIN1—Developmental Biology—TNF—Graves' disease	2.14e-05	0.00132	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TNF—Graves' disease	2.09e-05	0.00129	CbGpPWpGaD
Pethidine—ALB—Metabolism—GC—Graves' disease	2.09e-05	0.00128	CbGpPWpGaD
Pethidine—Somnolence—Methimazole—Graves' disease	2.05e-05	0.0524	CcSEcCtD
Pethidine—OPRM1—Signaling Pathways—TSHR—Graves' disease	2.05e-05	0.00126	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2RA—Graves' disease	2.02e-05	0.00125	CbGpPWpGaD
Pethidine—Oedema—Propylthiouracil—Graves' disease	1.96e-05	0.0501	CcSEcCtD
Pethidine—OPRM1—GPCR downstream signaling—IL2RA—Graves' disease	1.88e-05	0.00116	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—B3GNT2—Graves' disease	1.88e-05	0.00116	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GC—Graves' disease	1.87e-05	0.00115	CbGpPWpGaD
Pethidine—Urticaria—Methimazole—Graves' disease	1.83e-05	0.0468	CcSEcCtD
Pethidine—Somnolence—Propylthiouracil—Graves' disease	1.74e-05	0.0445	CcSEcCtD
Pethidine—CYP2D6—Metabolism—GC—Graves' disease	1.72e-05	0.00106	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2RA—Graves' disease	1.71e-05	0.00105	CbGpPWpGaD
Pethidine—Pruritus—Methimazole—Graves' disease	1.63e-05	0.0417	CcSEcCtD
Pethidine—ALB—Hemostasis—IL2RA—Graves' disease	1.6e-05	0.000983	CbGpPWpGaD
Pethidine—ALB—Metabolism—B3GNT2—Graves' disease	1.58e-05	0.000974	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL10—Graves' disease	1.56e-05	0.000963	CbGpPWpGaD
Pethidine—Urticaria—Propylthiouracil—Graves' disease	1.55e-05	0.0398	CcSEcCtD
Pethidine—Vomiting—Methimazole—Graves' disease	1.46e-05	0.0374	CcSEcCtD
Pethidine—Rash—Methimazole—Graves' disease	1.45e-05	0.0371	CcSEcCtD
Pethidine—Dermatitis—Methimazole—Graves' disease	1.45e-05	0.0371	CcSEcCtD
Pethidine—Headache—Methimazole—Graves' disease	1.44e-05	0.0369	CcSEcCtD
Pethidine—CYP2C19—Metabolism—B3GNT2—Graves' disease	1.42e-05	0.000874	CbGpPWpGaD
Pethidine—Pruritus—Propylthiouracil—Graves' disease	1.38e-05	0.0354	CcSEcCtD
Pethidine—Nausea—Methimazole—Graves' disease	1.37e-05	0.035	CcSEcCtD
Pethidine—OPRM1—Signaling Pathways—CXCL10—Graves' disease	1.32e-05	0.000814	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—B3GNT2—Graves' disease	1.31e-05	0.000804	CbGpPWpGaD
Pethidine—Vomiting—Propylthiouracil—Graves' disease	1.24e-05	0.0318	CcSEcCtD
Pethidine—Rash—Propylthiouracil—Graves' disease	1.23e-05	0.0316	CcSEcCtD
Pethidine—Dermatitis—Propylthiouracil—Graves' disease	1.23e-05	0.0315	CcSEcCtD
Pethidine—Headache—Propylthiouracil—Graves' disease	1.23e-05	0.0314	CcSEcCtD
Pethidine—OPRK1—Signaling Pathways—IL2RA—Graves' disease	1.2e-05	0.000736	CbGpPWpGaD
Pethidine—Nausea—Propylthiouracil—Graves' disease	1.16e-05	0.0297	CcSEcCtD
Pethidine—CYP3A4—Metabolism—GC—Graves' disease	1.13e-05	0.000694	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2RA—Graves' disease	1.01e-05	0.000622	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—B3GNT2—Graves' disease	8.53e-06	0.000526	CbGpPWpGaD
